APA (7th ed.) Citation

Hey, J. A., Yu, J. Y., Abushakra, S., Schaefer, J. F., Power, A., Kesslak, P., . . . Tolar, M. (2025). Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer’s Disease. Clinical pharmacokinetics, 64(3), 407-424. https://doi.org/10.1007/s40262-025-01482-8

Chicago Style (17th ed.) Citation

Hey, John A., Jeremy Y. Yu, Susan Abushakra, Jean F. Schaefer, Aidan Power, Pat Kesslak, Jijo Paul, and Martin Tolar. "Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer’s Disease." Clinical Pharmacokinetics 64, no. 3 (2025): 407-424. https://doi.org/10.1007/s40262-025-01482-8.

MLA (9th ed.) Citation

Hey, John A., et al. "Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer’s Disease." Clinical Pharmacokinetics, vol. 64, no. 3, 2025, pp. 407-424, https://doi.org/10.1007/s40262-025-01482-8.